Lisinopril and Hydrochlorothiazide - lisinopril and hydrochlorothiazide
Navigation: NDC > Supplier starting with: M > MYLAN PHARMACEUTICALS INC.| Field | Value |
|---|---|
| NDC Code: | 0378-2025 |
| Proprietary Name: | Lisinopril and Hydrochlorothiazide |
| Suffix: | |
| Non-Proprietary Name: | lisinopril and hydrochlorothiazide |
| Dosage Form: | TABLET |
| Method: | ORAL |
| Original Marketing Date: | 22-01-2013 |
| Category Name: | ANDA |
| Application Number: | ANDA076113 |
| Labeler: | MYLAN PHARMACEUTICALS INC. |
| Substance Name: | HYDROCHLOROTHIAZIDE; LISINOPRIL |
| Active Numerator Strength: | 25; 20 |
| Active Ingredient Unit: | mg/1; mg/1 |
| Pharm Classes: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| DEA Schedule: |